Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ConjugateBio
Princeton, New Jersey, United Statesbioworld.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
ConjugateBio is a Princeton, New Jersey-based biotech company specializing in next-generation antibody-drug conjugate technologies. The company has entered into multiple high-value licensing agreements with international partners to develop novel ADCs using its proprietary platforms. Recent deals include a $250 million agreement with Pinotbio for up to 10 ADC targets and an exclusive option agreement with Shijian Bio for the EZWi-Fit platform. Clinical results have not been published as the company's focus appears to be on preclinical research and technology outlicensing rather than direct product commercialization at this stage[1][3].
- Therapeutic areas
- Oncology
- Modalities
- Antibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Partnerships
Pinotbio Co. Ltd. (South Korea): $250M deal for up to 10 ADC targets using Pinotbio’s platform technology[3][4]Shijian Bio (China): Exclusive option/license agreement for EZWi-Fit platform use in certain ADC applications, potential value over $100M plus royalties[1]
Beyond the preview
Go deeper on ConjugateBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ConjugateBio.